Skip to main content

Find Clinical Trials

Home
Conditions
Waldenstrom Macroglobulinemia

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

397 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Completed

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

NCT00083707

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma

NCT00126646

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Terminated

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

NCT01947140

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Terminated

Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim

NCT04947618

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: CHU Nimes Nîmes, Gard, France

View Trial Details